韩国研究人员开发高度敏感的气压纳米材料,用于检测血液样本中的癌症变异基因。 South Korean researchers develop highly sensitive plasmonic nanomaterials for detecting cancer mutant genes in blood samples.
韩国研究人员李明英博士和朴成奎博士开发了一种利用气压纳米材料的开拓性技术,可以检测血液样本中的癌症变异基因,其灵敏度达到0.000001%,这是前所未有的。 South Korean researchers Dr. Min-young Lee and Dr. Sung-gyu Park have developed a groundbreaking technology using plasmonic nanomaterials that can detect cancer mutant genes in blood samples with an unprecedented sensitivity of 0.000000001%. 这种方法可以进行早期癌症诊断、监测治疗效果和个性化治疗计划,在发现肺癌病人的EGFR突变方面达到96%的准确度。 This method allows for early cancer diagnosis, monitoring treatment effectiveness, and personalized treatment plans, achieving 96% accuracy in detecting EGFR mutations in lung cancer patients. 研究承诺加强癌症管理,减少对侵入性程序的需求。 The research promises to enhance cancer management and reduce the need for invasive procedures.